Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 864–865 | Cite as

ASO Author Reflections: Parathyroid Carcinoma—Setting the Stage for Prognosis

  • Winifred M. Lo
  • Dhaval T. PatelEmail author
ASO Author Reflections



Winifred M. Lo and Dhaval T. Patel have no conflicts of interest to disclose.


  1. 1.
    Lee PK, Jarosek SL, Virnig BA et al. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109(9):1736–41.CrossRefGoogle Scholar
  2. 2.
    Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol. 2012;13(1):11–23.CrossRefGoogle Scholar
  3. 3.
    Asare EA, Sturgeon C, Winchester DJ, et al. Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the National Cancer Data Base (NCDB). Ann Surg Oncol. 2015;22(12):3990–5.CrossRefGoogle Scholar
  4. 4.
    Lo WM, Good ML, Nilubol N, Perrier ND, and Patel DT. Tumor size and presence of metastatic disease at diagnosis are associated with disease-specific survival in parathyroid carcinoma. Ann Surg Oncol. 2018;25:2535–2540.CrossRefGoogle Scholar
  5. 5.
    Harari A, Waring A, Fernandez-Ranvier G, et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;96(12):3679–86.CrossRefGoogle Scholar

Copyright information

© This is a U.S. government work and its text is not subject to copyright protection in the United States; however, its text may be subject to foreign copyright protection 2018

Authors and Affiliations

  1. 1.Thoracic and Gastrointestinal Oncology BranchNational Cancer InstituteBethesdaUSA
  2. 2.Endocrine Oncology Branch, National Institutes of HealthCenter for Cancer ResearchBethesdaUSA

Personalised recommendations